Spruce Biosciences, Inc. (NASDAQ:SPRB) Receives $170.10 Average Target Price from Analysts

Spruce Biosciences, Inc. (NASDAQ:SPRB) Receives $170.10 Average Target Price from Analysts

Spruce Biosciences, Inc. (NASDAQ:SPRB – Get Free Report) has received an average recommendation of “Hold” from the eight ratings firms that are presently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and four have issued a buy rating on the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year …